melphalan and Hemorrhagic-Disorders

melphalan has been researched along with Hemorrhagic-Disorders* in 4 studies

Other Studies

4 other study(ies) available for melphalan and Hemorrhagic-Disorders

ArticleYear
[Haemorrhagic diathesis as an early symptom of systemic amyloidosis].
    Deutsche medizinische Wochenschrift (1946), 2006, Jan-05, Volume: 131, Issue:1-2

    A 63-year-old man, known to have Bechterev's disease was admitted because of weight gain and nocturnal sweating. He also had signs of heart failure with progressive exertional dyspnoea. Many months previously numerous bleedings had occurred in the skin, predominantly the face (periorbital and perioral), the inguinal region and the penis.. Extensive diagnostic test failed to find any evidence of tumor. The Rumpel-Leede tourniquet test was positive, while platelet functions was normal, suggesting vascular disease. The skin biopsy showed many perivascular amyloid deposits (AL). Immunochemical differentiation also demonstrated the same amyloid in rectal and hepatic biopsies. But there was AA amyloid in a hepatic artery. Immunophoresis indicated a biclonal gammopahty of unknown significance.. These findings indicated the diagnosis of primary AL amyloidosis associated with a gammopathy of unknown significance and a secondary AA amyloidosis in the presence of chronic Bechterev s disease. The clinical picture also showed cardiac complications, predominantly heart failure and numerous previous myocardial infarctions without S-T elevations. Echocardiography, which revealed marked thickening of the left ventricle with a restrictive filling pattern, suggested cardiac co-morbidity. The patient underwent chemotherapy with melphalan and prednisone but had a sudden cardiac death.. In a case of bleeding of unknown cause systemic amyloidosis should be considered in the differential diagnosis. A tendency towards bleeding, as in this patient, may be the first sign of amyloidosis, which ist often diagnosed quite late in the course of the disease.

    Topics: Amyloidosis; Death, Sudden, Cardiac; Diagnosis, Differential; Fatal Outcome; Glucocorticoids; Heart Failure; Hemorrhagic Disorders; Humans; Male; Melphalan; Middle Aged; Myocardial Infarction; Paraproteinemias; Prednisone; Spondylitis, Ankylosing

2006
Diagnosis and management of monoclonal gammopathies.
    The Veterinary clinics of North America, 1977, Volume: 7, Issue:1

    Topics: Animals; Bence Jones Protein; Blood Viscosity; Cat Diseases; Cats; Dog Diseases; Dogs; Hemorrhagic Disorders; Hypercalcemia; Hypergammaglobulinemia; Kidney Diseases; Lymphoma, Non-Hodgkin; Melphalan; Multiple Myeloma; Waldenstrom Macroglobulinemia

1977
[CURRENT CLINICAL ASPECTS, DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA (ON THE 90TH ANNIVERSARY OF THE DESCRIPTION OF MULTIPLE MYELOMA BY O. A. RUSTITSKI I].
    Klinicheskaia meditsina, 1964, Volume: 42

    Topics: Amyloidosis; Anniversaries and Special Events; Blood Protein Disorders; Cryoglobulins; Drug Therapy; Hemorrhagic Disorders; Humans; Melphalan; Multiple Myeloma

1964
MYELOMATOSIS. A CLINICAL AND BIOCHEMICAL STUDY OF 105 CASES.
    Acta medica Scandinavica, 1964, Volume: 176

    Topics: Blood Cell Count; Blood Protein Electrophoresis; Blood Sedimentation; Bone Marrow Examination; Calcium; Drug Therapy; Electrophoresis; Geriatrics; Hemoglobinometry; Hemorrhagic Disorders; Humans; Hypercalcemia; Immunoelectrophoresis; Kidney Function Tests; Melphalan; Multiple Myeloma; Neoplasms; Radiography; Urethane; Urine

1964